Constitutive activation of PKA catalytic subunit in adrenal Cushing’s syndrome
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Corticotropin-independent Cushing's syndrome is caused by tumors or hyperplasia of the adrenal cortex. The molecular pathogenesis of cortisol-producing adrenal adenomas is not well understood. METHODS: We performed exome sequencing of tumor-tissue specimens from 10 patients with cortisol-producing adrenal adenomas and evaluated recurrent mutations in candidate genes in an additional 171 patients with adrenocortical tumors. We also performed genomewide copy-number analysis in 35 patients with cortisol-secreting bilateral adrenal hyperplasias. We studied the effects of these genetic defects both clinically and in vitro. RESULTS: Exome sequencing revealed somatic mutations in PRKACA, which encodes the catalytic subunit of cyclic AMP-dependent protein kinase (protein kinase A [PKA]), in 8 of 10 adenomas (c.617A→C in 7 and c.595_596insCAC in 1). Overall, PRKACA somatic mutations were identified in 22 of 59 unilateral adenomas (37%) from patients with overt Cushing's syndrome; these mutations were not detectable in 40 patients with subclinical hypercortisolism or in 82 patients with other adrenal tumors. Among 35 patients with cortisol-producing hyperplasias, 5 (including 2 first-degree relatives) carried a germline copy-number gain (duplication) of the genomic region on chromosome 19 that includes PRKACA. In vitro studies showed impaired inhibition of both PKA catalytic subunit mutants by the PKA regulatory subunit, whereas cells from patients with germline chromosomal gains showed increased protein levels of the PKA catalytic subunit; in both instances, basal PKA activity was increased. CONCLUSIONS: Genetic alterations of the catalytic subunit of PKA were found to be associated with human disease. Germline duplications of this gene resulted in bilateral adrenal hyperplasias, whereas somatic PRKACA mutations resulted in unilateral cortisol-producing adrenal adenomas. (Funded by the European Commission Seventh Framework Program and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic activating mutations of protein kinase A catalytic subunit (PRKACA) has been implicated in up to 50% of patients with adenomas with clinical Cushing’s syndrome, but not in adenomas producing less cortisol (138,142,147).”
From Adrenal incidentaloma (2020) · cites this paper as [147]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these mutations, the most frequently found (PKA-CL205R) is a point mutation leading to substitution of Leu at position 205 (or 206, depending on the convention used for numbering) with Arg and has been found in up to 67% of Cushing’s syndrome patients (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The L205R mutation was discovered independently in our laboratory and in other laboratories as the dominant genetic alteration in cortisol-producing adrenocortical adenomas responsible for Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Later on, our group and others discovered single mutations or insertions at the R/C interface that are linked to adrenal Cushing’s syndrome (3–7).”
From Cushing’s syndrome driver mutation disrupts protein kinase A allosteric network, altering both regulation and substrate specificity (2019) · cites this paper as [6]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As expected, the 60-minute post-ACTH cortisol was higher than the 30-minute cortisol on each of the cortisol assays evaluated [26, 28, 38].”
From New Cutoffs for the Biochemical Diagnosis of Adrenal Insufficiency after ACTH Stimulation using Specific Cortisol Assays (2021) · cites this paper as [38]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationNewell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Kirschner, L. S., Carney, J. A., Pack, S. D., Taymans, S. E., Giatzakis, C., Cho, Y. S., Cho-Chung, Y. S., & Stratakis, C. A. (2000) · Nature Genetics · doi:10.1038/79238 · Cited by 1,153
Self-citationManagement of the clinically inapparent adrenal mass ("incidentaloma")
Grumbach, M. M., Biller, B. M. K., Braunstein, G. D., Campbell, K. K., Carney, J. A., Godley, P. A., Harris, E. L., Lee, J. K. T., Oertel, Y. C., Posner, M. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-5-200303040-00013 · Cited by 945 · cited 1×
“Adrenal adenomas are common, with a prevalence of at least 3% among persons older than 50 years of age.(3) Whereas only a subset of these tumors is associated with overt Cushing’s syndrome, some degree of cortisol excess is present, depending on the diagnostic criteria applied,(4) in up to 47% of patients with adrenal…”
BackgroundThe clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7093 · Cited by 619
Beuschlein, F., Boulkroun, S., Osswald, A., Wieland, T., Nielsen, H. N., Lichtenauer, U. D., Penton, D., Schack, V. R., Amar, L., Fischer, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2550 · Cited by 577
Self-citationPersistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors
Calebiro, D., Nikolaev, V. O., Gagliani, M. C., de Filippis, T., Dees, C., Tacchetti, C., Persani, L., & Lohse, M. J. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000172 · Cited by 574
Self-citationIncidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study
Lindholm, J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.117 · Cited by 507
Assembly of allosteric macromolecular switches: lessons from PKA
Taylor, S. S., Ilouz, R., Zhang, P., & Kornev, A. P. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3432 · Cited by 477
Research works printed but not linked: 1
- Bertherat J, 2003, Cancer Res, 63, 5308
Cited by
Items 101–200 of 475
Molecular Genetic and Genomic Alterations in Cushing’s Syndrome and Primary Aldosteronism
Kamilaris, C. D. C., Stratakis, C. A., & Hannah‐Shmouni, F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.632543 · Cited by 47
Self-citationGenetics of primary macronodular adrenal hyperplasia
Fragoso, M. C. B. V., Alencar, G. A., Lerario, A. M., Bourdeau, I., Almeida, M. Q., Mendonca, B. B., & Lacroix, A. (2015) · Journal of Endocrinology · doi:10.1530/joe-14-0568 · Cited by 46
cAMP signaling in cortisol-producing adrenal adenoma
Calebiro, D., Di Dalmazi, G., Bathon, K., Ronchi, C. L., & Beuschlein, F. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0353 · Cited by 45
Self-citationCui, Y., Miao, Y., Cao, L., Guo, L., Cui, Y., Yan, C., Zeng, Z., Xu, M., & Han, T. (2023) · Nature Communications · doi:10.1038/s41467-023-41101-3 · Cited by 45
Pathway‐based personalized analysis of breast cancer expression data
Livshits, A., Git, A., Fuks, G., Caldas, C., & Domany, E. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.04.006 · Cited by 45
Functional Implications of LH/hCG Receptors in Pregnancy-Induced Cushing Syndrome
Plöckinger, U., Chruściel, M., Doroszko, M., Saeger, W., Blankenstein, O., Weizsäcker, K., Kroiß, M., Hauptmann, K., Radke, C., Pöllinger, A., et al. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1021 · Cited by 45
Self-citationTaylor, S. S., Søberg, K., Kobori, E., Wu, J., Pautz, S., Herberg, F. W., & Skålhegg, B. S. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000315 · Cited by 44
Ronchi, C. L., Kroiß, M., Sbiera, S., Deutschbein, T., & Faßnacht, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0273 · Cited by 44
Self-citationEffects of Chronic ACTH Excess on Human Adrenal Cortex
BERTAGNA, X. Y. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00043 · Cited by 44
Targeted Mutational Analysis of Cortisol-Producing Adenomas
Rege, J., Hoxie, J. M., Liu, C.-J., Cash, M. N., Luther, J. M., Gellert, L. L., Turcu, A. F., Else, T., Giordano, T. J., Udager, A. M., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab682 · Cited by 43
Protein Kinase A in neurological disorders
Glebov-McCloud, A. G. P., Saide, W. S., Gaine, M. E., & Strack, S. (2024) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09525-0 · Cited by 42
Cortisol overproduction results from DNA methylation of CYP11B1 in hypercortisolemia
Kometani, M., Yoneda, T., Demura, M., Koide, H., Nishimoto, K., Mukai, K., Gómez-Sánchez, C. E., Akagi, T., Yokota, T., Horike, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11435-2 · Cited by 42
Update on the Genetics of Pituitary Tumors
Barry, S., & Korbonits, M. (2020) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2020.05.005 · Cited by 42
Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations
Nanba, K., Omata, K., Tomlins, S. A., Giordano, T. J., Hammer, G. D., Rainey, W. E., & Else, T. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0262 · Cited by 42
The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway
Bolger, G. B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1024423 · Cited by 42
Li, S., Fell, S. M., Surova, O. V., Smedler, E., Wallis, K., Chen, Z. X., Hellman, U., Johnsen, J. I., Martinsson, T., Kenchappa, R. S., et al. (2016) · Developmental Cell · doi:10.1016/j.devcel.2015.12.029 · Cited by 42
Alterations in Protein Kinase A Substrate Specificity as a Potential Cause of Cushing Syndrome
Bathon, K., Weigand, I., Vanselow, J. T., Ronchi, C. L., Sbiera, S., Schlosser, A., Fassnacht, M., & Calebiro, D. (2019) · Endocrinology · doi:10.1210/en.2018-00775 · Cited by 42
Self-citationAlmahariq, M. F., Mei, F. C., & Cheng, X. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv115 · Cited by 41
Dopamine-Secreting Pheochromocytoma and Paraganglioma
Miyamoto, S., Yoshida, Y., Ozeki, Y., Okamoto, M., Gotoh, K., Masaki, T., Nishida, H., Shibuya, T., Shin, T., Daa, T., et al. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab163 · Cited by 41
cAMP-specific PDE4 phosphodiesterases and AIP in the pathogenesis of pituitary tumors
Bolger, G. B., Bizzi, M. F., Pinheiro, S. V. B., Trivellin, G., Smoot, L. H. M., Accavitti, M. A., Korbonits, M., & Ribeiro‐Oliveira, A. (2016) · Endocrine Related Cancer · doi:10.1530/erc-15-0205 · Cited by 41
Update on subclinical Cushing's syndrome
Nieman, L. K. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000159 · Cited by 40
Genetics of Adrenocortical Development and Tumors
Lodish, M. B. (2017) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.01.007 · Cited by 40
Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome
Vaduva, P., Bonnet-Serrano, F., & Bertherat, J. Y. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa075 · Cited by 40
Self-citationBilateral Adrenal Hyperplasia: Pathogenesis and Treatment
Chevalier, B., Vantyghem, M., & Espiard, S. (2021) · Biomedicines · doi:10.3390/biomedicines9101397 · Cited by 40
Hernández-Ramírez, L. C., Trivellin, G., & Stratakis, C. A. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.006 · Cited by 40
Self-citationJouinot, A., & Bertherat, J. Y. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_9 · Cited by 39
Self-citationTwo-pore domain potassium channels in the adrenal cortex.
Bandulik, S., Tauber, P., Lalli, E., Barhanin, J., & Warth, R. (2015) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1628-6 · Cited by 38
“The central role of PKA signaling for cortisol synthesis was recently underlined by the observation that a somatic gain-of-function mutation of PKA is present in about 50 % of patients with cortisol-producing adrenal adenomas [12, 15, 47, 117].”
BackgroundInsights from exome sequencing for endocrine disorders
de Bruin, C., & Dauber, A. N. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.72 · Cited by 38
Alterations of Phosphodiesterases in Adrenocortical Tumors
Hannah‐Shmouni, F., Faucz, F. R., & Stratakis, C. A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00111 · Cited by 38
Self-citationMislocalization of protein kinase a drives pathology in cushing’s syndrome
Omar, M. H., Byrne, D. P., Jones, K. N., Lakey, T. M., Collins, K. B., Lee, K.-S., Daly, L. A., Forbush, K. A., Lau, H.-T., Golkowski, M., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111073 · Cited by 38
Tang, C., Liu, D., Fan, Y., Yu, J. G., Li, C., Su, J., & Wang, C. (2020) · Journal of Cancer · doi:10.7150/jca.47158 · Cited by 38
Design and Profiling of a Subcellular Targeted Optogenetic cAMP-Dependent Protein Kinase
O’Banion, C. P., Priestman, M. A., Hughes, R. M., Herring, L. E., Capuzzi, S. J., & Lawrence, D. S. (2017) · Cell chemical biology · doi:10.1016/j.chembiol.2017.09.011 · Cited by 37
Lucia, K. E., Wu, Y., Garcia, J. L. M., Barlier, A., Buchfelder, M., Saeger, W., Renner, U., Stalla, G. K., & Theodoropoulou, M. (2020) · Oncogene · doi:10.1038/s41388-020-1223-6 · Cited by 37
The human adrenal cortex: growth control and disorders
Lotfi, C. F. P., Kremer, J. L., Passaia, B. D. S., & Cavalcante, I. P. (2018) · Clinics · doi:10.6061/clinics/2018/e473s · Cited by 37
The Adrenal Cortex and Its Disorders
Miller, W. L., Flück, C. E., Breault, D. T., & Feldman, B. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00014-2 · Cited by 37
Subclinical hypercortisolism in adrenal incidentaloma
Debono, M., & Newell-Price, J. (2015) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000151 · Cited by 36
Weigand, I., Ronchi, C. L., Rizk‐Rabin, M., Dalmazi, G. D., Wild, V., Bathon, K., Rubin, B., Calebiro, D., Beuschlein, F., Bertherat, J. Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00125-8 · Cited by 36
Self-citationCell signaling pathways in the adrenal cortex: Links to stem/progenitor biology and neoplasia
Penny, M. K., Finco, I., & Hammer, G. D. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.005 · Cited by 36
Bram, Z., Louiset, E., Ragazzon, B., Renouf, S., Wils, J., Duparc, C., Boutelet, I., Rizk‐Rabin, M., Libé, R., Young, J., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87958 · Cited by 36
Self-citationLorigo, M., Oliveira, N., & Cairrão, E. (2021) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9010004 · Cited by 36
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 35
Genetics of Cushing’s disease: an update
Perez‐Rivas, L. G., & Reincke, M. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0353-0 · Cited by 35
Self-citationUncovering Aberrant Mutant PKA Function with Flow Cytometric FRET
Lee, S.-R., Sang, L., & Yue, D. T. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.077 · Cited by 34
Nakajima, Y., Okamura, T., Gohko, T., Satoh, T., Hashimoto, K., Shibusawa, N., Ozawa, A., Ishii, S., Tomaru, T., Horiguchi, K., et al. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0282 · Cited by 34
Local Control of Aldosterone Production and Primary Aldosteronism
Lalli, E., Barhanin, J., Zennaro, M., & Warth, R. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.01.003 · Cited by 34
Taylor, S. S., Wallbott, M., Machal, E. M. F., Søberg, K., Ahmed, F., Bruystens, J., Vu, L., Baker, B., Wu, J., Raimondi, F., et al. (2021) · Biochemical Journal · doi:10.1042/bcj20200867 · Cited by 34
Altieri, B., Secener, K., Sai, S., Fischer, C., Sbiera, S., Arampatzi, P., Kircher, S., Herterich, S., Landwehr, L., Vitcetz, S. N., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1798 · Cited by 33
Self-citationParacrine control of steroidogenesis by serotonin in adrenocortical neoplasms
Lefèbvre, H., Duparc, C., Prévost, G., Zennaro, M., Bertherat, J. Y., & Louiset, E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.013 · Cited by 33
Self-citationRecurrent driver mutations in benign tumors
Gomes, C. C. (2022) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2022.108412 · Cited by 33
New advances in endocrine hypertension: from genes to biomarkers
Fernandes-Rosa, F. L., Boulkroun, S., Fedlaoui, B., Hureaux, M., Travers, S. A. A., Drossart, T., Favier, J., & Zennaro, M. (2023) · Kidney International · doi:10.1016/j.kint.2022.12.021 · Cited by 32
Charchar, H. L. S., & Fragoso, M. C. B. V. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac041 · Cited by 31
The genetically encoded tool set for investigating cAMP: more than the sum of its parts
Patel, N. P., & Gold, M. G. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00164 · Cited by 31
Asser, L., Hescot, S., Viengchareun, S., Delemer, B., Trabado, S., & Lombès, M. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.07.012 · Cited by 30
Chambre, C., McMurray, E. M., Baudry, C., Lataud, M., Guignat, L., Gaujoux, S., Lahlou, N., Guibourdenche, J., Tissier, F., Sibony, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0036 · Cited by 30
Self-citationGenomics of benign adrenocortical tumors
Jouinot, A., Armignacco, R., & Assié, G. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105414 · Cited by 30
Self-citationCushing's syndrome mutant PKA L 205R exhibits altered substrate specificity
Lubner, J. M., Dodge‐Kafka, K. L., Carlson, C. R., Church, G. M., Chou, M. F., & Schwartz, D. (2017) · FEBS Letters · doi:10.1002/1873-3468.12562 · Cited by 30
Swimming regulations for protein kinase a catalytic subunit
Gold, M. G. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190230 · Cited by 30
Fallo, F., Castellano, I., Gómez-Sánchez, C. E., Rhayem, Y., Pilon, C., Vicennati, V., Santini, D., Maffeis, V., Fassina, A., Mulatero, P., et al. (2017) · Endocrine · doi:10.1007/s12020-017-1295-4 · Cited by 29
Self-citationMete, Ö., & Duan, K. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00054 · Cited by 29
Genetics of micronodular adrenal hyperplasia and Carney complex
Tirosh, A., Valdés, N., & Stratakis, C. A. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2018.07.005 · Cited by 29
Self-citationCastro, M. A., & Marazuela, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.913253 · Cited by 29
Creemers, S. G., Feelders, R. A., de Jong, F. H., Franssen, G. J. H., de Rijke, Y. B., van Koetsveld, P. M., & Hofland, L. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa989 · Cited by 29
ARMC5-CUL3 E3 ligase targets full-length SREBF in adrenocortical tumors
Okuno, Y., Fukuhara, A., Otsuki, M., & Shimomura, I. (2022) · JCI Insight · doi:10.1172/jci.insight.151390 · Cited by 29
Adrenal Cortex Development and Maintenance: Knowledge Acquired From Mouse Models
Nader, N. A., & Boyer, A. (2021) · Endocrinology · doi:10.1210/endocr/bqab187 · Cited by 28
Stratakis, C. A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3295 · Cited by 28
Self-citationUpdate of Genetic and Molecular Causes of Adrenocortical Hyperplasias Causing Cushing Syndrome
Berthon, A. S., & Bertherat, J. Y. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1061-7349 · Cited by 27
Self-citationItcho, K., Oki, K., Gómez-Sánchez, C. E., Gómez-Sánchez, E. P., Ohno, H., Kobuke, K., Nagano, G., Yoshii, Y., Baba, R., Hattori, N., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.14062 · Cited by 26
A pan-tissue survey of mosaic chromosomal alterations in 948 individuals
Gao, T., Kastriti, M. E., Ljungström, V., Heinzel, A., Tischler, A. S., Oberbauer, R. W., Loh, P., Adameyko, I. I., Park, P. J., & Kharchenko, P. V. (2023) · Nature Genetics · doi:10.1038/s41588-023-01537-1 · Cited by 26
Cell-To-Cell Communication in Bilateral Macronodular Adrenal Hyperplasia Causing Hypercortisolism
Lefèbvre, H., Duparc, C., Prévost, G., Bertherat, J. Y., & Louiset, E. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00034 · Cited by 26
Self-citationWalker, C., Wang, Y., Olivieri, C., V.S, M., Gao, J., Bernlohr, D. A., Calebiro, D., Taylor, S. S., & Veglia, G. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167123 · Cited by 25
Self-citationGenetic Alterations in Benign Adrenal Tumors
Pitsava, G., & Stratakis, C. A. (2022) · Biomedicines · doi:10.3390/biomedicines10051041 · Cited by 25
Self-citationNovel Insights into the Genetics and Pathophysiology of Adrenocortical Tumors
Drougat, L., Omeiri, H., Lefèvre, L., & Ragazzon, B. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00096 · Cited by 25
Update on Genetics of Primary Aldosteronism
Itcho, K., Oki, K., Ohno, H., & Yoneda, M. (2021) · Biomedicines · doi:10.3390/biomedicines9040409 · Cited by 25
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma
Scatolini, M., Grisanti, S., Tomaiuolo, P., Grosso, E., Basile, V., Cosentini, D., Puglisi, S., Laganà, M., Perotti, P., Saba, L., et al. (2024) · European Journal of Cancer · doi:10.1016/j.ejca.2024.114088 · Cited by 24
Mestre, J. L., Duparc, C., Reznik, Y., Bonnet-Serrano, F., Touraine, P. A., Chabre, O., Young, J., Suzuki, M., Sibony, M., Gobet, F., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00425 · Cited by 24
Self-citationProtein kinase A defects and cortisol-producing adrenal tumors
Zilbermint, M. F., & Stratakis, C. A. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000149 · Cited by 23
Self-citationRemde, H., Kranz, S., Morell, S. M., Altieri, B., Kroiß, M., Detomas, M., Faßnacht, M., & Deutschbein, T. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1123132 · Cited by 23
Genetics of adrenocortical tumours
Åkerström, T., Carling, T., Beuschlein, F., & Hellman, P. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12452 · Cited by 23
Self-citationA Gene-Based Classification of Primary Adrenocortical Hyperplasias
Hannah‐Shmouni, F., & Stratakis, C. A. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1107-2972 · Cited by 23
Self-citationDiagnosing endocrine hypertension: a practical approach
Yang, J., Shen, J., & Fuller, P. J. (2017) · Nephrology · doi:10.1111/nep.13078 · Cited by 22
Berthon, A. S., Hannah‐Shmouni, F., Maria, A. G., Faucz, F. R., & Stratakis, C. A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.02.011 · Cited by 22
Self-citationMouse Models Recapitulating Human Adrenocortical Tumors: What Is Lacking?
Leccia, F., Batisse‐Lignier, M., Sahut‐Barnola, I., Val, P., Lefrançois‐Martinez, A., & Martinez, A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00093 · Cited by 21
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update
Bouys, L., Vaczlavik, A., Cavalcante, I. P., Violon, F., Jouinot, A., Berthon, A. S., Vaduva, P., Espiard, S., Perlemoine, K., Kamenický, P., et al. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03554-1 · Cited by 21
Self-citationPRKACB variants in skeletal disease or adrenocortical hyperplasia: effects on protein kinase A
Espiard, S., Drougat, L., Settas, N., Haydar, S., Bathon, K., London, E., Levy, I., Faucz, F. R., Calebiro, D., Bertherat, J. Y., et al. (2020) · Endocrine Related Cancer · doi:10.1530/erc-20-0309 · Cited by 21
Self-citationThe Role of Genetic and Epigenetic Changes in Pituitary Tumorigenesis
Fukuoka, H., & Takahashi, Y. (2014) · Neurologia medico-chirurgica · doi:10.2176/nmc.ra.2014-0184 · Cited by 21
Revisión del complejo de Carney: Aspectos genéticos
Schamun, M. B. B., Correa, R., Graffigna, P., de Miguel, V., & Day, P. (2017) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2017.09.006 · Cited by 21
Basso, F., Rocchetti, F., Rodriguez, S., Nesterova, M., Cormier, F., Stratakis, C. A., Ragazzon, B., Bertherat, J. Y., & Rizk‐Rabin, M. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1389951 · Cited by 21
Self-citationProtein kinase A and local signaling in cancer
Rosenthal, K. J., Gordan, J. D., & Scott, J. D. (2024) · Biochemical Journal · doi:10.1042/bcj20230352 · Cited by 20
CTNNB1Mutation in Aldosterone Producing Adenoma
Wang, J., Peng, K., Wu, V., Tseng, F., & Wu, K. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.3.332 · Cited by 20
Classification of Cushing's syndrome PKAc mutants based upon their ability to bind PKI
Omar, M. H., Kihiu, M., Byrne, D. P., Lee, K., Lakey, T. M., Butcher, E. R., Eyers, P. A., & Scott, J. D. (2023) · Biochemical Journal · doi:10.1042/bcj20230183 · Cited by 20
Drougat, L., Settas, N., Ronchi, C. L., Bathon, K., Calebiro, D., Maria, A. G., Haydar, S., Voutetakis, A., London, E., Faucz, F. R., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-00958-1 · Cited by 20
Self-citationMicroinsertions in PRKACA cause activation of the protein kinase A pathway in cardiac myxoma
Tseng, I., Huang, W., Jhuang, Y., Chang, Y., Hsu, H., & Jeng, Y. (2017) · The Journal of Pathology · doi:10.1002/path.4899 · Cited by 20
Stratakis, C. A. (2018) · The Journal of Pathology · doi:10.1002/path.5014 · Cited by 20
Self-citationGao, X., Yamazaki, Y., Tezuka, Y., Pieroni, J., Ishii, K., Atsumi, N., Ono, Y., Omata, K., Morimoto, R., Nakamura, Y., et al. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105764 · Cited by 19
The next step: mechanisms driving adrenocortical carcinoma metastasis
Lalli, E., & Luconi, M. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0440 · Cited by 19
PRKACA Mutations in Adrenal Adenomas: Genotype/Phenotype Correlations
Dalmazi, G. D., & Beuschlein, F. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-120416 · Cited by 19
Self-citationMechanisms of Aberrant PKA Activation by Cα Subunit Mutations
Calebiro, D., Bathon, K., & Weigand, I. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0042-112817 · Cited by 19
Self-citationCushingʼs syndrome in childhood: update on genetics, treatment, and outcomes
Lodish, M. B. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000127 · Cited by 19
Olivieri, C., Wang, Y., Walker, C., Subrahmanian, M. V., Ha, K. N., Bernlohr, D., Gao, J., Camilloni, C., Vendruscolo, M., Taylor, S. S., et al. (2024) · eLife · doi:10.7554/elife.91506.3 · Cited by 18
Hedgehog pathway, cell cycle, and primary cilium
Zhuang, T. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02605-7 · Cited by 18
Metadata
- Authors
- Beuschlein, F., Fassnacht, M., Assié, G., Calebiro, D., Stratakis, C. A., Osswald, A., Ronchi, C. L., Wieland, T., Sbiera, S., Faucz, F. R., Schaak, K., Schmittfull, A., Schwarzmayr, T., Barreau, O., Vezzosi, D., Rizk-Rabin, M., Zabel, U., Szarek, E., Salpea, P., Forlino, A., Vetro, A., Zuffardi, O., Kisker, C., Diener, S., Meitinger, T., Lohse, M. J., Reincke, M., Bertherat, J., Strom, T. M., & Allolio, B.
- Affiliations
- University of Würzburg (DE)
- Centre National de la Recherche Scientifique (FR)
- National Institutes of Health (US)
- Helmholtz Munich (DE)
- University of Pavia (IT)
- Policlinico San Matteo Fondazione (IT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-03-13
- Volume
- 370
- Issue
- 11
- Pages
- 1019-1028
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC4727447
- OpenAlex
- W2040816499
- Cited by
- 443
- References
- 40
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 28 · 2023: 26 · 2022: 39 · 2021: 40 · 2020: 28 · 2019: 25 · 2018: 34 · 2017: 38 · 2016: 51 · 2015: 50 · 2014: 38
- FWCI
- 58.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- George Washington University
- Johns Hopkins University
- Cedars-Sinai Medical Center
- Quest Diagnostics
- Otsuka America
- European Commission (259735)
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZIAHD008920)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- Cushing's syndrome, adrenal hyperplasia, PRKACA, protein kinase A catalytic subunit, somatic mutations, adrenocortical tumors, hypercortisolism
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adrenal Hyperplasia, Congenital, Adult, Cushing Syndrome, Humans, Hydrocortisone, Middle Aged, Mutation, Protein Conformation, Sequence Analysis, DNA, Cyclic AMP-Dependent Protein Kinases, Germ-Line Mutation, Catalytic Domain, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.